Hepatitis Monthly

Published by: Kowsar

Analysis of Antigenic and Conformational Changes in Hepatitis B Surface Antigen (HBsAg) Identified in Iranian Patients with Chronic Hepatitis B

Vahdat Poortahmasebi 1 , 2 , Mansour Poorebrahim 3 , Azam Ghaziasadi 1 , Mohammad Foad Abazari 4 , Sayed-Hamidreza Mozhgani 2 , Maryam Nouri Aleagha 4 , Forouzan Shahbazi 4 and Seyed Moayed Alavian 1 , 5 , *
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Hepatitis B Molecular Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, IR Iran
5 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
Article information
  • Hepatitis Monthly: September 2017, 17 (9); e57882
  • Published Online: September 3, 2017
  • Article Type: Research Article
  • Received: July 29, 2017
  • Revised: July 29, 2017
  • Accepted: August 28, 2017
  • DOI: 10.5812/hepatmon.57882

To Cite: Poortahmasebi V, Poorebrahim M, Ghaziasadi A, Abazari M F, Mozhgani S, et al. Analysis of Antigenic and Conformational Changes in Hepatitis B Surface Antigen (HBsAg) Identified in Iranian Patients with Chronic Hepatitis B, Hepat Mon. 2017 ;17(9):e57882. doi: 10.5812/hepatmon.57882.

Abstract
Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107[DOI][PubMed]
  • 2. European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2): 370-98[DOI][PubMed]
  • 3. Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology. 1992; 33(3): 148-58[DOI][PubMed]
  • 4. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985; 317(6037): 489-95[DOI][PubMed]
  • 5. Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci. 2007; 1(2): 62-70[DOI][PubMed]
  • 6. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 7. Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013; 57(3): 201-8[DOI][PubMed]
  • 8. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, et al. Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iran J Public Health. 2012; 41(3): 104-11[PubMed]
  • 9. Ie SI, Thedja MD, Roni M, Muljono DH. Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J. 2010; 7: 326[DOI][PubMed]
  • 10. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990; 336(8711): 325-9[DOI][PubMed]
  • 11. Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, et al. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study. J Viral Hepat. 2013; 20(7): 494-501[DOI][PubMed]
  • 12. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008; 9: 40[DOI][PubMed]
  • 13. Yang J, Zhang Y. Protein Structure and Function Prediction Using I-TASSER. Curr Protoc Bioinformatics. 2015; 52: 5 8 1-15[DOI][PubMed]
  • 14. Dindoost P, Jazayeri SM, Karimzadeh H, Saberfar E, Miri SM, Alavian SM. HBsAg variants: Common escape issues. Jundishapur J Microbiol. 2012; 5(4): 521-7[DOI]
  • 15. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res. 2008; 36-8[DOI][PubMed]
  • 16. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997; 4 Suppl 1: 11-20[DOI][PubMed]
  • 17. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, et al. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest. 1992; 90(6): 2543-7[DOI][PubMed]
  • 18. Wu C, Deng W, Deng L, Cao L, Qin B, Li S, et al. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol. 2012; 86(8): 4658-69[DOI][PubMed]
  • 19. Ponsel D, Bruss V. Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol. 2003; 77(1): 416-22[DOI][PubMed]
  • 20. Gomez-Gutierrez J, Rodriguez-Crespo I, Gonzalez-Ros JM, Ferragut JA, Paul DA, Peterson DL, et al. Thermal stability of hepatitis B surface antigen S proteins. Biochim Biophys Acta. 1992; 1119(3): 225-31[DOI][PubMed]
  • 21. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995; 345(8962): 1406-7[DOI][PubMed]
  • 22. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol. 1994; 68(4): 2671-6[PubMed]
  • 23. Lehninger AL, Nelson DL, Cox MM. Lehninger principles of biochemistry. 1993; : 111-33
  • 24. Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, Alavian SM, et al. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016; 16(7)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader